LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

Home・Aktien・Pliant Therapeutics Inc

Pliant Therapeutics Inc

Geschlossen

1.14 -4.2

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.12

Max

1.17

Schlüsselkennzahlen
By Trading Economics
Einkommen	17M -26M
Angestellte	171
EBITDA	19M -23M

Dividenden
By Dow Jones
Nächstes Ergebnis	26. Feb. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-31M 72M
Vorheriger Eröffnungskurs	5.34
Vorheriger Schlusskurs	1.14

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

1.43 / 1.6 Unterstützung & Widerstand

Pliant Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

11. Feb. 2026, 23:47 UTC

Heiße Aktien

Stocks to Watch: AppLovin, Cisco, Cognex, Pilgrim's Pride

11. Feb. 2026, 22:59 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Grab Holdings to Buy U.S.-Based Stash Financial

11. Feb. 2026, 23:54 UTC

Ergebnisse

McDonald's Says Its Value Campaign Is Paying Off -- 2nd Update

11. Feb. 2026, 23:50 UTC

Market Talk

Global Equities Roundup: Market Talk

11. Feb. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Takaichi's Economic Steps -- Market Talk

11. Feb. 2026, 23:49 UTC

Ergebnisse

Singtel: Key Focus Areas Are Strengthening Core Businesses, Scaling Growth Engines, Building Momentum Across Regional Associates >Z74.SG

11. Feb. 2026, 23:45 UTC

Ergebnisse

Singtel: Net Exceptional Gain of S$1.15B in 3Q Primarily From Sale of Partial Stake in Bharti Airtel>Z74.SG

11. Feb. 2026, 23:42 UTC

Ergebnisse

Singtel 3Q Underlying Net Profit S$744M Vs. S$680M >Z74.SG

11. Feb. 2026, 23:41 UTC

Ergebnisse

Singtel 3Q Net S$1.89B Vs. Net S$1.32B >Z74.SG

11. Feb. 2026, 23:40 UTC

Ergebnisse

Singtel 3Q Operating Revenue S$3.66B Vs. S$3.63B >Z74.SG

11. Feb. 2026, 23:35 UTC

Market Talk

Gold Falls on Prospects of Long Fed Pause -- Market Talk

11. Feb. 2026, 23:18 UTC

Market Talk

AppLovin CEO Looks to Soothe Concerns Over AI, Competition -- Market Talk

11. Feb. 2026, 23:14 UTC

Market Talk

RBA Governor Faces Barrage of Questions About Govt Spending -- Market Talk

11. Feb. 2026, 22:59 UTC

Ergebnisse

Kakao 2025 Net KRW525.72B Vs. Loss KRW161.87B >035720.SE

11. Feb. 2026, 22:59 UTC

Ergebnisse

Kakao 2025 Oper Pft KRW732.04B Vs. Pft KRW460.21B >035720.SE

11. Feb. 2026, 22:59 UTC

Ergebnisse

Kakao 2025 Rev KRW8.099T Vs. KRW7.872T >035720.SE

11. Feb. 2026, 22:58 UTC

Ergebnisse

Kakao 4Q Net Loss Missed FactSet-Compiled Consensus

11. Feb. 2026, 22:57 UTC

Ergebnisse

Kakao 4Q Loss KRW39.30B Vs. Loss KRW395.21B >035720.SE

11. Feb. 2026, 22:54 UTC

Ergebnisse

Kakao 4Q Oper Pft KRW203.45B Vs. Pft KRW75.43B >035720.SE

11. Feb. 2026, 22:53 UTC

Ergebnisse

Kakao 4Q Rev KRW2.133T Vs. KRW1.957T >035720.SE

11. Feb. 2026, 22:47 UTC

Ergebnisse

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11. Feb. 2026, 22:47 UTC

Ergebnisse

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11. Feb. 2026, 22:23 UTC

Ergebnisse

Grab Holdings Expects to Close Stash Acquisition in 3Q of 2026 >GRAB

11. Feb. 2026, 22:22 UTC

Ergebnisse

Grab Holdings to Acquire U.S. Digital Financial Services Company Stash Financial >GRAB

11. Feb. 2026, 22:22 UTC

Ergebnisse

Grab Holdings Sees FY26 Adj Ebitda $700M to $720M >GRAB

11. Feb. 2026, 22:19 UTC

Ergebnisse

Grab Holdings Sees FY26 Rev $4.04B to $4.10B >GRAB

11. Feb. 2026, 22:18 UTC

Ergebnisse

Grab Holdings 4Q Adj Ebitda $148.0M Vs. $97.0M >GRAB

11. Feb. 2026, 22:18 UTC

Ergebnisse

Grab Holdings 4Q Net $153.0M Vs. Net $11.0M >GRAB

11. Feb. 2026, 22:18 UTC

Ergebnisse

Grab Holdings 4Q Oper Pft $52.0M Vs. $2.0M >GRAB

11. Feb. 2026, 22:16 UTC

Ergebnisse

Grab Holdings 4Q Rev $906.0M Vs. $764.0M >GRAB

Peer-Vergleich

Kursveränderung

Pliant Therapeutics Inc Prognose

Rating-Konsens

By TipRanks

Sell

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Pliant Therapeutics Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

1.43 / 1.6Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

There is one bearish event.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.